UNITED THERAPEUTICS Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.2 | $2.9 | $2.3 | $1.9 | $1.7 |
| Operating income | $1.5 | $1.4 | $1.2 | $1.0 | $0.6 |
| Net income | $1.3 | $1.2 | $1.0 | $0.7 | $0.5 |
| Cash Flow Statement | |||||
| Free cash flow | $1.0 | $1.1 | $0.7 | $0.7 | $0.5 |
| Share repurchases | $1.0 | $1.0 | $0.0 | $0.0 | — |
Shares outstanding 42.9M · Free float 85.4%
Annual filing data through FY ended December 31, 2025; float as of October 10, 2026.